Albumin and surgical site infection risk in orthopaedics: a meta-analysis

BMC Surgery

Table 1 Characteristics of selected studies for dichotomous variable meta-analysis

First author, Year	Country	Study design	Age (year)	Year of operation	Time of Infection	Type of surgery	Type of infection	Infection group		No infection group		NOS
First author, Year	Country	Study design	Age (year)	Year of operation	Time of Infection	Type of surgery	Type of infection	albumin <3.5	albumin >3.5	albumin <3.5	albumin >3.5	NOS
DM Masatu, 2010 [16]	Tanzania	Cohort	36.11 ± 14.38	3–12,2009	30 days	femoral fractures	SSI	7	2	18	73	7
Lan B.MC Phee, 1998 [9]	Australia	Cohort	infection 54 ± 13, primary 53 ± 17	11/1984–5/1995	not mentioned	spine metastases	SSI	9	5	47	9	6
Owoicho Adogwa, 2014 [4]	US	Cohort	53.8 ± 17.0	2011–2013	12 months	spine fusion surgery	deep	2	2	55	77
Owoicho Adogwa, 2014 [4]	US	Cohort	53.8 ± 17.0	2011–2013	12 months	spine fusion surgery	superficial	1	0	56	79	7
Charles L Nelson, 2015 [12]	US	Cohort	not mentioned	2006–2013	during hospitalization	TKA	superficial	20	228	1546	35,298	8
							deep	6	42	1560	35,484	8
							Organ space	7	54	1559	35,472	8
Carlos J. Lavernia, 1999 [11]	US	Cohort	64.6 ± 15.62	1/-1-31/12, 1997	during hospitalization	THA and TKA	deep	1	2	21	95	7
Klein, Jeffrey D, 1996 [15]	US	Cohort	45	1990–1992	3 Year	lumber decompression and fusion	SSI	9	2	20	83	7
Jason D. Walls, 2015 [5]	US	Cohort	not mentioned	2006–2013	30 days	THA	superficial	24	164	1098	22,952	7
							deep	8	62	1114	23,054	7
							Organ space	3	46	1119	23,070	7
Hiroyuki Hayashi, 2015 [19]	Japan	Cohort	53.8	4/2006–6/2013	not mentioned	spondylectomy	SSI	2	6	16	101	8
Daniel D. Bohl, 2015 [18]	US	Cohort	not mentioned	2011–2013	30 days	THA and TKA	SSI	45	457	1919	47,182	8

ISSN: 1471-2482